Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Category: Crisis Management
FDA Resource: Molnupiravir received EUA approval from the FDA
The FDA has granted molnupiravir emergency use authorization (EUA) to treat mild to moderate COVID-19 in adults at high risk of severe illness. High risk people include adults aged 65 and over and people with certain medical conditions. The FDA also states that molnupiravir sh...
IDSA Resources: Neurology
SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Infectious Diseases Society of America (IDSA) COVID-19 Real-Time Learning Network. These resources are categorized as Neurology
I Cannot Let It Go
From Pediatric Critical Care Medicine . In this Editorial, the authors discuss the article by Vacheron et al. on the epidemiology of ventilatory-associated pneumonia among patients with COVID-19.
What Will Endemic COVID-19 Mean in the ICU?
Learn how COVID-19 is becoming an endemic condition in intensive care units in this FREE SCCM webcast. Subject matter experts will also discuss COVID-19 myths and misconceptions and how COVID-19 has changed the continuum of care.
The Society of Critical Care Medicine and th...